Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Change in Account Payables: 2023-2024

Historic Change in Account Payables for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $3.3 million.

  • CG Oncology's Change in Account Payables rose 395.66% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year increase of 92.96%. This contributed to the annual value of $3.3 million for FY2024, which is 62.77% up from last year.
  • According to the latest figures from FY2024, CG Oncology's Change in Account Payables is $3.3 million, which was up 62.77% from $2.0 million recorded in FY2023.
  • CG Oncology's 5-year Change in Account Payables high stood at $3.3 million for FY2024, and its period low was $2.0 million during FY2023.
  • Moreover, its 2-year median value for Change in Account Payables was $2.6 million (2023), whereas its average is $2.6 million.
  • Data for CG Oncology's Change in Account Payables shows a peak YoY skyrocketed of 62.77% (in 2024) over the last 5 years.
  • Over the past 2 years, CG Oncology's Change in Account Payables (Yearly) stood at $2.0 million in 2023, then soared by 62.77% to $3.3 million in 2024.